Clinical characteristics of COVID-19 cases and healthy controls in the discovery cohort. by Feng Gao (3548)

Subjects:

Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

Subjects:

Analysis of the correlation between pharyngeal microbiomics, metabolomics and clinical indicators between OC and HC. by Feng Gao (3548)

Subjects:

S1 File - Global burden and risk factors of peptic ulcer disease between 1990 and 2021: An analysis from the global burden of disease study 2021 by Wende Hao (10315597)

Subjects:

Metabolome KEGG enrichment analysis of serum in Omicron variant cases and recovered cases. by Feng Gao (3548)

Subjects:

Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 2021. by Wende Hao (10315597)

Subjects:

Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 1990. by Wende Hao (10315597)

Subjects:

Clinical symptoms scoring system. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Lost cases. by Nan Tang (642590)

Serologic changes in 8 representative cases of sub-serostatus and clinical interpretation groups. by Ei Kinai (212480)

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. by Yongqin Wu (272012)

Number of adverse reaction case reports of finasteride administration at the PT level. by Xiaoling Zhong (181270)

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate (per set) in each organism between the control and bundle periods. by Miki Doi (15347878)

Subjects:

Reasons for the determination of blood culture contamination for each organism. by Miki Doi (15347878)

Subjects:

Protocol for blood culture during the control period. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of sterile blood transfer devices. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of skin disinfection swab sets in the hospital. by Miki Doi (15347878)

Subjects:

Organisms causing bacterial culture contamination and the contamination rate for each organism during the study period. by Miki Doi (15347878)

Subjects: